Company Description
Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
We have designed our platform to address a broad spectrum of MSK (musculoskeletal system) care—from acute injury, to chronic pain, to post-surgical rehabilitation.
Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches.
Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life.
To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers, third-party administrators, and other ecosystem entities to efficiently provide our platform to clients and members.
| Country | United States |
| Founded | 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,437 |
| CEO | Daniel Perez |
Contact Details
Address: 455 Market Street, Suite 700 San Francisco, CA 94105 United States | |
| Phone | (415) 726-2206 |
| Website | hingehealth.com |
Stock Details
| Ticker Symbol | HNGE |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001673743 |
| Employer ID | 81-1884841 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Daniel Perez | Chief Executive Officer, Co-Founder, and Director |
| James Budge | Chief Financial Officer |
| Jim Pursley | President |
| Gabriel Mecklenburg | Executive Chairman, Co-Founder, and Director |
| Kristina Leslie | Director |
| Elliott Robinson | Director |
| Teddie Wardi | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 7, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Mar 10, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Feb 14, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jan 17, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 15, 2024 | DRS | [Cover] Draft Registration Statement |
| Dec 28, 2023 | D | Notice of Exempt Offering of Securities |
| Dec 21, 2023 | D | Notice of Exempt Offering of Securities |
| Apr 1, 2021 | D | Notice of Exempt Offering of Securities |
| Jul 1, 2020 | D | Notice of Exempt Offering of Securities |
| Jul 1, 2020 | D | Notice of Exempt Offering of Securities |